Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.